Synopsis : Mankind Pharma is planning to invest up to Rs 200 crore in the first two to three years in the…
Pharmanews
-
-
Europe Medicine Agency (EMA)Regulatory
EMA establishes a Cancer Medicines Forum to optimize Cancer Treatments in Clinical practice
by adminby adminSummary EMA has launched the Cancer Medicines Forum (CMF) in collaboration with the European Organization for Research and Treatment of Cancer (EORTC).…
-
Covid DrugsPharma Science & Research
Alpaca nanobodies potently neutralize SARS-CoV-2 variants
by adminby adminSummary : Researchers at Karolinska Institutet in Sweden have developed a novel strategy for identifying potent miniature antibodies, so-called nanobodies, against emerging…
-
CompaniesCovid DrugsPfizer
Pfizer and BioNTech receive expanded U.S. emergency use authorization for an additional COVID-19 vaccine booster in individuals aged 50 years and older
by adminby adminSummary: Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded…
-
RegulatoryU.S FDA
Telix Granted FDA Orphan Drug Designation for Bone Marrow Conditioning Treatment
by adminby adminSummary : Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States Food and Drug Administration (FDA) has…
-
RegulatoryU.S FDA
CANbridge Pharmaceuticals CAN108 New Drug Application/Orphan Drug Registration (NDA/ORD) for Alagille Syndrome Accepted by the Taiwan Food and Drug Administration
by adminby adminSummary Taiwan Food and Drug Administration (TFDA) has accepted the New Drug Application/Orphan Drug Registration (NDA/ODR) for CAN108 (maralixibat oral solution (LIVMARLI TM))…
-
Aurobindo PharmaceuticalsMerger / Acquisition
Aurobindo Pharma amass Veritaz Healthcare for Rs 171 crore
by adminby adminSummary Pharma major Aurobindo Pharmaceuticals on Monday said it has acquired the business and certain assets of Veritaz Healthcare Limited (VHL) for…
-
RegulatoryU.S FDA
IQVIA selected to accelerate clinical development of VYVGART by argenx SE
by adminby adminSynopsis : IQVIA announced an agreement today with argenx SE. The multi-year contract covers a unique collaboration for the development of new…
-
Summary : Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced…
-
Global Market
AbbVie, Eli Lilly, Novartis and more cut back in Russia amid corporate exodus over Ukraine war
by adminby adminSummary : Since the invasion of Ukraine, hundreds of companies have announced a pause or withdrawal of businesses in Russia. Drugmakers Eli…